Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$8.39
+1.82%
Mkt Cap $1.45B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
Implied Upside
+5.1%
Consensus $8.82 vs current $8.39
NASDAQ·Healthcare·Biotechnology
$8.39
+1.82%
Mkt Cap $1.45B
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
+5.1%
Consensus $8.82 vs current $8.39